Lower Drug Price Advocates Chafe At Trump’s Bid To Hobble March-In

Advocates for lower drug prices say the Commerce Department’s eleventh-hour proposal to prohibit the government from using high prices as a reason to license third parties to make drugs and vaccines developed with federal funding is a give-away to the drug industry. Commerce’s National Institute of Science and Technology proposed the rule Jan. 4, and the incoming Biden administration is expected to put it on hold along with other last-minute rules proposed by the Trump administration in order to review...